Tim Luker, PhD
VP Lilly Ventures
Eli Lilly
Tim Luker, Ph.D., is currently VP Lilly Ventures at Eli Lilly. He leads Lilly’s venture external innovation process on the West Coast USA within Global Corporate Business Development, primarily targeting transformational early-stage research across all therapy and functional areas. This role supports Lilly’s multiple external venture fund investments globally (>$2.5 billion+) and due diligence and search and evaluation initiatives. He has completed over 40 signed deals across multiple modalities and therapeutic areas for Lilly. Previously, Tim is an experienced drug hunter with over 20 years’ experience (60+ patents and publications). Prior to Lilly he worked at Shire, Polleo Pharma (founder, company acquired) and AstraZeneca. Tim has a Ph.D. in chemistry from the University of Southampton, UK, carried out post-doctoral research at Universiteit Van Amsterdam and is a Prince2 qualified project manager.
Sessions
-
24-Jun-2026Theater 2Eli Lilly and Company



